- Home
- RPRX vs IP Comparison
RPRX vs IP Comparison
Compare RPRX & IP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | IP |
|---|---|---|
| Founded | 1996 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 21.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | IP |
|---|---|---|
| Price | $46.15 | $37.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $47.75 | ★ $48.50 |
| AVG Volume (30 Days) | 2.7M | ★ 5.4M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 2.06% | ★ 4.97% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.30 | $7.71 |
| Revenue Next Year | $4.80 | $3.88 |
| P/E Ratio | $25.63 | ★ N/A |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $29.66 | $35.45 |
| 52 Week High | $47.86 | $56.64 |
Technical Indicators
Market Signals| Indicator | RPRX | IP |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 34.99 |
| Support Level | $44.94 | $36.95 |
| Resistance Level | $46.14 | $39.52 |
| Average True Range (ATR) | 0.92 | 1.64 |
| MACD | -0.23 | -0.72 |
| Stochastic Oscillator | 39.36 | 25.47 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About IP International Paper Company
International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one-third of the North American corrugated packaging market. The company also has a substantial presence in Europe following its acquisition of DS Smith. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.